The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...
Researchers found that vaccine effectiveness was 80% and 81% against RSV-associated hospitalizations and against RSV-associated critical illness among 28,271 hospitalizations for RSV-like illness ...